Vajdic, C.M.Mayson, E.Dodds, A.J.O'Brien, T.Wilcox, L.Nivison-Smith, I.Le Marsney, R.Daniels, B.Ashton, L.J.Tan, J.Bilmon, I.Aarons, D.Tran, S.Gibson, J.Johnston, A.Greenwood, M.Forbes, M.Hertzberg, M.Huang, G.Spencer, A.et al.2020-07-022020-07-022016Biology of Blood and Marrow Transplantation, 2016; 22(5):949-9561083-87911523-6536http://hdl.handle.net/2440/126339Abstract not available.en© 2016 American Society for Blood and Marrow Transplantation.Allogeneic transplantation; malignancy; mortality; risk; surveillance; preventionJournal article100001762210.1016/j.bbmt.2016.01.0272-s2.0-84963652800260346